During week 29 of 2026 (July 13-17), Sampo Oyj bought back 968,363 of its own A-shares across multiple markets at a weighted average price of €9.53 per share. This buyback is part of a program authorized by the company's annual general meeting in April 2026, with a total budget of up to €350 million. After these transactions, Sampo holds 17,103,871 A-shares, representing 0.64% of all its shares. The buyback program aims to enhance shareholder value and optimize the company's capital structure.
The global antiparasitic drugs market is projected to grow from $23.3 billion in 2026 to $30.98 billion by 2032, driven by persistent parasitic diseases, drug resistance, and climate change. Innovations focus on resistance-ready therapies, pediatric ...
The global activewear market is projected to grow from $439.74 billion in 2026 to $650.97 billion by 2032, at a CAGR of 6.59%. Growth is fueled by the rise of athleisure as everyday wear, increased health and fitness participation, and demand for ver...
JCDecaux has launched its programmatic digital Out-of-Home (pDOOH) advertising across nine Latin American countries, including Panama, Costa Rica, and Ecuador. This move allows brands to automate and optimize campaigns on over 4,600 digital screens, ...
JCDecaux has connected its entire Digital Out-of-Home (DOOH) inventory to programmatic buying across nine Latin American countries, including Panama, Costa Rica, and Ecuador. This move allows advertisers to plan and optimize campaigns more precisely ...
Immix Biopharma is under investigation by Block & Leviton for potential securities fraud after it was revealed that an executive using the name Richard Graydon was actually a fugitive operating under a false identity. The company fired the individual...
